A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Multiple Escalating Oral Doses Of Pf-06427878 Co-administered With And Without Food In Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Multiple Escalating Oral Doses Of Pf-06427878 Co-administered With And Without Food In Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs PF 6427878 (Primary)
  • Indications Hyperlipidaemia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Dec 2015 Planned End Date changed from 1 Nov 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
    • 23 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top